{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T21:41:58Z","timestamp":1780695718626,"version":"3.54.1"},"reference-count":38,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,6,13]],"date-time":"2022-06-13T00:00:00Z","timestamp":1655078400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"abstract":"<jats:p>There are few studies on the changes of gut microbiota in patients with gallstones, especially in patients with asymptomatic gallstones, and there are some deficiencies in these studies, for instance, the effects of metabolic factors on gut microbiota are not considered. Here, we selected 30 asymptomatic gallstone patients from the survey population, and 30 controls according to the age and BMI index matching principle. The 16SrDNA technology was used to detect and compare the structural differences in the gut microbiota between the two groups. Compared with healthy controls, the abundance of gut microbiota in patients with gallstones increased significantly, while the microbiota diversity decreased. At the level of phylum, both groups were dominated by <jats:italic>Firmicutes<\/jats:italic>, <jats:italic>Bacteroides<\/jats:italic>, <jats:italic>Proteobacteria<\/jats:italic>, and <jats:italic>Actinobacteria<\/jats:italic>. At the genus level, there were 15 species with significant differences in abundance between the two groups. Further subgroup analysis found that only unclassified <jats:italic>Lactobacillales<\/jats:italic> showed differences in the intestines of gallstones patients with hypertension, non-alcoholic fatty liver disease, or patients with elevated BMI (\u226724). The structure of gut microbiota in patients with gallstones changed significantly, and this might be related to the occurrence of gallstones, rather than metabolic factors such as hypertension, non-alcoholic fatty liver disease, and obesity.<\/jats:p>","DOI":"10.3389\/fmicb.2022.882265","type":"journal-article","created":{"date-parts":[[2022,6,13]],"date-time":"2022-06-13T05:56:12Z","timestamp":1655099772000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":22,"title":["Gut Microbial Profile in Asymptomatic Gallstones"],"prefix":"10.3389","volume":"13","author":[{"given":"Sen-Tao","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling-Yan","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Fen","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,6,13]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"3018","DOI":"10.1016\/j.jacc.2019.03.507","article-title":"ACC\/AHA versus ESC\/ESH on hypertension guidelines: JACC guideline comparison.","volume":"73","author":"Bakris","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1002\/hep.20788","article-title":"Primary biliary cirrhosis is characterized by IgG3 antibodies cross-reactive with the major mitochondrial autoepitope and its Lactobacillus mimic.","volume":"42","author":"Bogdanos","year":"2005","journal-title":"Hepatology"},{"key":"B3","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1097\/MOG.0000000000000423","article-title":"An update on the pathogenesis of cholesterol gallstone disease.","volume":"34","author":"Di Ciaula","year":"2018","journal-title":"Curr. Opin. Gastroenterol."},{"key":"B4","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1136\/gutjnl-2012-303611","article-title":"Butyricicoccus pullicaecorum in inflammatory bowel disease.","volume":"62","author":"Eeckhaut","year":"2013","journal-title":"Gut"},{"key":"B5","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.jhep.2016.03.005","article-title":"EASL Clinical Practice Guidelines on the prevention, diagnosis and treatment of gallstones.","volume":"65","year":"2016","journal-title":"J. Hepatol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/s0016-5085(99)70456-7","article-title":"Prevalence and ethnic differences in gallbladder disease in the United States.","volume":"117","author":"Everhart","year":"1999","journal-title":"Gastroenterology"},{"key":"B7","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1111\/joim.12584","article-title":"Roles of the gut in the metabolic syndrome: an overview.","volume":"281","author":"Fandriks","year":"2017","journal-title":"J. Intern. Med."},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3390\/jpm11010013","article-title":"Gallstone disease, obesity and the firmicutes\/bacteroidetes ratio as a possible biomarker of gut dysbiosis.","volume":"11","author":"Grigor\u2019eva","year":"2020","journal-title":"J. Pers. Med."},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.3158","article-title":"Standards of medical care for type 2 diabetes in China 2019.","volume":"35","author":"Jia","year":"2019","journal-title":"Diabetes Metab. Res. Rev."},{"key":"B10","first-page":"163","article-title":"Guidelines for management of nonalcoholic fatty liver disease: an updated and revised edition.","volume":"18","author":"Jian-Gao","year":"2010","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"key":"B11","doi-asserted-by":"publisher","first-page":"3341","DOI":"10.2337\/db13-0844","article-title":"Assessing the human gut microbiota in metabolic diseases.","volume":"62","author":"Karlsson","year":"2013","journal-title":"Diabetes"},{"key":"B12","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1111\/j.1572-0241.2002.05425.x","article-title":"Gram-positive cocci are associated with the formation of completely pure cholesterol stones.","volume":"97","author":"Kawai","year":"2002","journal-title":"Am. J. Gastroenterol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1111\/1758-2229.12319","article-title":"Interactions between the intestinal microbiota and bile acids in gallstones patients.","volume":"7","author":"Keren","year":"2015","journal-title":"Environ. Microbiol. Rep."},{"key":"B14","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2016.24","article-title":"Gallstones.","volume":"2","author":"Lammert","year":"2016","journal-title":"Nat. Rev. Dis. Primers"},{"key":"B15","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.clinre.2017.06.002","article-title":"Gut microbial profile in primary biliary cholangitis: towards bioindicators.","volume":"41","author":"Lemoinne","year":"2017","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"key":"B16","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/nrgastro.2016.85","article-title":"The role of the gut microbiota in NAFLD.","volume":"13","author":"Leung","year":"2016","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-016-0222-x","article-title":"Gut microbiota dysbiosis contributes to the development of hypertension.","volume":"5","author":"Li","year":"2017","journal-title":"Microbiome"},{"key":"B18","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1053\/j.gastro.2008.12.031","article-title":"Roles of infection, inflammation, and the immune system in cholesterol gallstone formation.","volume":"136","author":"Maurer","year":"2009","journal-title":"Gastroenterology"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1053\/j.gastro.2005.01.008","article-title":"Identification of cholelithogenic enterohepatic helicobacter species and their role in murine cholesterol gallstone formation.","volume":"128","author":"Maurer","year":"2005","journal-title":"Gastroenterology"},{"key":"B20","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1128\/CMR.13.4.534","article-title":"Classification, identification, and clinical significance of Proteus, Providencia, and Morganella.","volume":"13","author":"O\u2019Hara","year":"2000","journal-title":"Clin. Microbiol. Rev."},{"key":"B21","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1586\/17474124.2016.1109445","article-title":"Management of gallstones and its related complications.","volume":"10","author":"Portincasa","year":"2016","journal-title":"Expert Rev. Gastroenterol. Hepatol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.cmet.2013.01.003","article-title":"Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist.","volume":"17","author":"Sayin","year":"2013","journal-title":"Cell Metab."},{"key":"B23","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/MOG.0000000000000418","article-title":"Incidence of gallstone disease and complications.","volume":"34","author":"Shabanzadeh","year":"2018","journal-title":"Curr. Opin. Gastroenterol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1016\/j.bpg.2006.05.004","article-title":"Gallstone disease: epidemiology of gallbladder stone disease.","volume":"20","author":"Shaffer","year":"2006","journal-title":"Best Pract. Res. Clin. Gastroenterol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1111\/1751-2980.12857","article-title":"Prevalence and risk factors for gallstone disease: a population-based cross-sectional study.","volume":"21","author":"Song","year":"2020","journal-title":"J. Dig. Dis."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1053\/j.gastro.2017.04.028","article-title":"Gallstone disease and cancer risk: finding the bug in the system.","volume":"152","author":"Soreide","year":"2017","journal-title":"Gastroenterology"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/389537","article-title":"Role of the microbiota and antibiotics in primary sclerosing cholangitis.","volume":"2013","author":"Tabibian","year":"2013","journal-title":"Biomed. Res. Int."},{"key":"B28","doi-asserted-by":"publisher","first-page":"2574","DOI":"10.1111\/j.1462-2920.2009.01982.x","article-title":"Towards the human intestinal microbiota phylogenetic core.","volume":"11","author":"Tap","year":"2009","journal-title":"Environ. Microbiol."},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms8040573","article-title":"The controversial role of human gut lachnospiraceae.","volume":"8","author":"Vacca","year":"2020","journal-title":"Microorganisms"},{"key":"B30","doi-asserted-by":"crossref","first-page":"S406","DOI":"10.1194\/jlr.R800075-JLR200","article-title":"Biliary lipids and cholesterol gallstone disease.","author":"Wang","year":"2009","journal-title":"J. Lipid Res."},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1186\/s12876-020-01195-1","article-title":"Intestinal flora imbalance affects bile acid metabolism and is associated with gallstone formation.","volume":"20","author":"Wang","year":"2020","journal-title":"BMC Gastroenterol."},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1186\/s12876-017-0629-2","article-title":"Alteration of gut microbiota in association with cholesterol gallstone formation in mice.","volume":"17","author":"Wang","year":"2017","journal-title":"BMC Gastroenterol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1080\/17474124.2018.1533812","article-title":"Role of the biliary microbiome in gallstone disease.","volume":"12","author":"Wang","year":"2018","journal-title":"Expert Rev. Gastroenterol. Hepatol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/nature24628","article-title":"Salt-responsive gut commensal modulates TH17 axis and disease.","volume":"551","author":"Wilck","year":"2017","journal-title":"Nature"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2018.03096","article-title":"the core- and pan-genomic analyses of the genus comamonas: from environmental adaptation to potential virulence.","volume":"9","author":"Wu","year":"2018","journal-title":"Front. Microbiol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1038\/s41591-019-0458-7","article-title":"Metagenomic and metabolomic analyses reveal distinct stage-specific phenotypes of the gut microbiota in colorectal cancer.","volume":"25","author":"Yachida","year":"2019","journal-title":"Nat. Med."},{"key":"B37","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1038\/s41581-018-0018-2","article-title":"The gut microbiota and the brain-gut-kidney axis in hypertension and chronic kidney disease.","volume":"14","author":"Yang","year":"2018","journal-title":"Nat. Rev. Nephrol."},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3390\/jcm8010079","article-title":"The impact of cholecystectomy on the gut microbiota: a case-control study.","volume":"8","author":"Yoon","year":"2019","journal-title":"J. Clin. Med."}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2022.882265\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,13]],"date-time":"2022-06-13T05:56:19Z","timestamp":1655099779000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2022.882265\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,13]]},"references-count":38,"alternative-id":["10.3389\/fmicb.2022.882265"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2022.882265","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,13]]},"article-number":"882265"}}